Document Detail


Efficacy of benzbromarone in hyperuricemic patients associated with chronic kidney disease.
MedLine Citation:
PMID:  22132953     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
We have retrospectively evaluated the uric acid control status and renal function changes over a period of up to 7 years in 35 patients with renal impairment who had stage 3 or higher chronic kidney disease (CKD; stage 3 in 32 patients, stage 4 in 2 patients, and stage 5 in 1 patient) associated with hyperuricemia and were receiving monotherapy with benzbromarone as an antihyperuricemic drug. Serum uric acid levels significantly decreased from 8.5 ± 0.9 to 6.1 ± 0.8 mg/dL at 6 months and were subsequently controlled at less than 7.0 mg/dL in most patients. Most patients received benzbromarone at a dose of 25-50 mg/day, whereas 150-200 mg/day was used in some patients with stage 4 or 5 CKD. No significant changes in estimated glomerular filtration rate (eGFR) from the baseline value of 46.2 ± 11.5 mL/minute/1.73 m(2) were found after benzbromarone therapy. Although the renal function impairment did not improve by reducing the serum uric acid levels with benzbromarone, the renal function did not deteriorate further on the therapy. These results suggest that benzbromarone is applicable to the management of hyperuricemia associated with renal impairment.
Authors:
S Fujimori; K Ooyama; H Ooyama; H Moromizato
Related Documents :
10651363 - Oromandibular reconstruction for oncological purposes.
22318853 - Identifying arrhythmias in adults with congenital heart disease by 24-h ambulatory elec...
637423 - Continuous ambulatory peritoneal dialysis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Nucleosides, nucleotides & nucleic acids     Volume:  30     ISSN:  1532-2335     ISO Abbreviation:  Nucleosides Nucleotides Nucleic Acids     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2011-12-02     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100892832     Medline TA:  Nucleosides Nucleotides Nucleic Acids     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1035-8     Citation Subset:  IM    
Affiliation:
a Department of Internal Medicine , Teikyo University School of Medicine , Tokyo , Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effects of losartan/hydrochlorothiazide on serum uric Acid levels and blood pressure in hypertensive...
Next Document:  Relationship between hyperuricemia and chronic kidney disease.